Leadership Overview
Orchid Pharma has 4 executives leading key functions including strategy, information technology, global procurement, and corporate operations.
Focused on delivering high-quality healthcare solutions, Orchid Pharma maintains a commitment to innovation and corporate social responsibility while building a sustainable ecosystem for global pharmaceutical growth.
Focused on delivering high-quality healthcare solutions, Orchid Pharma maintains a commitment to innovation and corporate social responsibility while building a sustainable ecosystem for global pharmaceutical growth.
Leadership Roles at Orchid Pharma
Rajnish Rohatgi - Chief Executive Officer Orchid Ams
Rajnish Rohatgi, the Chief Executive Officer Orchid Ams at Orchid Pharma, directs the overarching strategic vision for the organization. Rohatgi architects long-term growth plans by aligning research capabilities with evolving market demands in the pharmaceutical sector. Overseeing the integration of manufacturing and marketing, the Chief Executive Officer Orchid Ams ensures that the company maintains a competitive edge across diverse therapeutic domains. This leadership role involves constant engagement with the Board to refine operational goals and expand the reach of pharmaceutical solutions to healthcare providers. By fostering a culture of innovation, Rajnish Rohatgi drives the company toward achieving new heights in efficiency and product development. The Chief Executive Officer Orchid Ams monitors global market trends to identify emerging opportunities, ensuring that the organizational ecosystem remains robust and responsive to the needs of international healthcare organizations seeking comprehensive, high-quality medical products.
Mani Sivaswamy - President
Mani Sivaswamy, the President at Orchid Pharma, oversees the daily execution of corporate objectives and ensures operational excellence across all business units. Sivaswamy directs the implementation of company-wide policies that promote innovation and corporate social responsibility, fostering a productive environment for all employees. Overseeing the alignment of research, manufacturing, and marketing, the President ensures that every department contributes effectively to the company's overarching mission of providing comprehensive pharmaceutical solutions. This leadership role involves managing cross-functional teams to resolve operational bottlenecks and improve overall organizational performance. Mani Sivaswamy collaborates with the executive team to refine business strategies, ensuring that the company remains responsive to the needs of healthcare organizations. By maintaining a focus on efficiency and growth, the President drives the company toward achieving its strategic goals, ultimately strengthening the reputation of the organization as a reliable partner in the global healthcare sector.
Pragati Patro - Head of IT (Chief Information Officer)
Pragati Patro, the Head of IT (Chief Information Officer) at Orchid Pharma, manages the digital infrastructure supporting the company's research and manufacturing operations. Patro designs secure data systems that facilitate seamless communication between global departments, ensuring that information flows efficiently across the entire pharmaceutical value chain. Overseeing the implementation of advanced analytics, the Head of IT (Chief Information Officer) provides the data-driven insights necessary for informed decision-making at the executive level. This role involves protecting critical intellectual property through rigorous cybersecurity protocols while modernizing legacy systems to improve operational agility. Pragati Patro collaborates with other leaders to integrate technology into the core business model, thereby enhancing the speed of pharmaceutical development. By optimizing digital workflows, the Head of IT (Chief Information Officer) supports the company's mission to deliver reliable healthcare solutions, ultimately strengthening the technological foundation required for sustained growth in the competitive pharmaceutical industry.
Navdeep Aggarwal - Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To
Navdeep Aggarwal, the Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To at Orchid Pharma, executes complex supply chain strategies to ensure the availability of essential pharmaceutical materials. Aggarwal directs large-scale projects that expand manufacturing capacity, ensuring that infrastructure investments align with the company's long-term production goals. Overseeing procurement operations, the Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To negotiates critical partnerships with suppliers to maintain cost-efficiency and quality standards across all therapeutic domains. This leadership role requires constant coordination with internal teams to streamline project timelines and mitigate risks in the global supply chain. Navdeep Aggarwal drives the optimization of procurement processes, which directly impacts the company's ability to provide affordable and effective pharmaceutical solutions to healthcare providers. By managing these vital operational functions, the Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To secures the resources necessary for the company to maintain its market position.
Explore Leadership Teams in Manufacturing
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth-largest pharmaceutical company globally. The company discovers, develops, manufactures, and delivers medicines and vaccines with a research and development focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. GSK's product portfolio includes specialty medicines, vaccines, and general medicines targeting conditions such as HIV, respiratory diseases, cancer, immuno-inflammation, anti-viral, central nervous system disorders, metabolic conditions, cardiovascular disease, urogenital conditions, anti-bacterial treatments, dermatology, and rare diseases. The company also offers over-the-counter products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. In July 2024, the company moved its global headquarters to New Oxford Street in central London, positioning itself within the city's Knowledge Quarter near world-class science and academic institutions including the Francis Crick Institute and King's College London. The new headquarters houses approximately 3,000 employees including the global leadership team and teams supporting research and development, supply chain, commercial operations, and corporate functions. GSK sells its products through wholesalers, pharmacies, hospitals, physicians, and other healthcare groups globally, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Company Leadership LT
PL
RH
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.
Company Leadership
WN
GY
SOHO Global Health is a pioneer in natural herbal-based medicine, focusing on innovative herbal research and the development of high-quality health products. Their product range includes immune boosters, children's multivitamins, and supplements aimed at improving overall health and wellness. The company is committed to harnessing Indonesia's natural resources and indigenous plants to enhance the health of its customers. SOHO Global Health aims to create positive societal impacts through strategic partnerships and a customer-centric approach.
Company Leadership RL
HS
PB
Tolmar Pharmaceuticals is a fully integrated pharmaceutical company focused on the innovative development, manufacturing, and commercialization of specialty pharmaceuticals across multiple therapeutic areas, including Urology. Tolmar global headquarters, product development and manufacturing facilities are based in Northern Colorado, while North America commercial headquarters is based in Buffalo Grove, Illinois.
Company Leadership AD
JL
SG
Frequently Asked Questions Regarding Orchid Pharma Top Executives and Leadership Team
